This Article Full Text Full Text (PDF) All Versions of this Article: 110/9/1069    most recent 01.CIR.0000140264.56496.76v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schindler, T. H. Articles by Schelbert, H. R. Search for Related Content PubMed PubMed Citation Articles by Schindler, T. H. Articles by Schelbert, H. R. Pubmed/NCBI databases Substance via MeSH Related Collections Pathophysiology Risk Factors Coronary imaging: angiography/ultrasound/Doppler/CC Nuclear cardiology and PET Endothelium/vascular type/nitric oxide Other Vascular biology

(Circulation. 2004;110:1069-1075.)
© 2004 American Heart Association, Inc.

Original Articles

Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors

Thomas H. Schindler, MD; Egbert U. Nitzsche, MD; Manfred Olschewski, MSc; Nobuhisa Magosaki, MD; Michael Mix, PhD; John O. Prior, MD PhD; Alvaro D. Facta, MD; Ulrich Solzbach, MD; Hanjoerg Just, MD; Heinrich R. Schelbert, MD PhD

From the Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, Calif (T.H.S., E.U.N., J.O.P., A.D.F., H.R.S.), and Division of Cardiology and Nuclear Medicine (T.H.S., E.U.N., M.M., U.S., H.J.) and Department for Medical Statistics (M.O.), University Freiburg, Freiburg, Germany.

Correspondence to Thomas H. Schindler, MD, Department of Pharmacology, David Geffen School of Medicine at UCLA, B2-045J CHS, Box 956948, Los Angeles, CA 90095-6948. E-mail tschindler{at}mednet.ucla.edu

Received February 11, 2004; de novo received April 20, 2004; accepted May 20, 2004.

Background— The goal of this study was to examine a possible association between systemic microinflammation, as reflected by C-reactive protein (CRP) serum levels, and coronary vasomotion in patients with coronary risk factors but with angiographically normal coronary arteries.

Methods and Results— Coronary vasomotor function was studied in response to cold pressor testing (CPT) in 71 patients with normal angiograms. In all patients, CPT-induced changes in epicardial luminal area (LA; mm²) were assessed with quantitative angiography. Within 20 days, myocardial blood flow (MBF) responses to CPT were measured (mL · g^–1 · min^–1) noninvasively with ¹³N-ammonia and PET imaging. The CPT-induced mean changes in LA and in MBF in patients with elevated CRP (0.5 mg/dL) were significantly impaired compared with patients presenting with CRP levels within normal range (<0.5 mg/dL) (LA, –1.09±0.86 versus 0.45±0.63 mm²; MBF, 0.06±0.18 versus 0.44±0.31 mL · g^–1 · min^–1; P<0.0001, respectively). Coronary LA changes and MBF responses to CPT were inversely correlated with CRP serum levels (r=–0.84 and r=–0.63; P<0.0001). Lastly, regression analysis revealed a significant correlation between the changes in LA and MBF during CPT for patients with elevated CRP levels and those for patients with normal CRP levels (r=0.56 and r=0.66; P<0.001).

Conclusions— These findings suggest a direct association between systemic microinflammation and altered coronary vasomotor function of both the epicardial conductance and the arteriolar resistance vessels.

Key Words: blood flow • C-reactive protein • coronary disease • endothelium • inflammation

This article has been cited by other articles:

				F. M. Bengel, T. Higuchi, M. S. Javadi, and R. Lautamaki Cardiac positron emission tomography. J. Am. Coll. Cardiol., June 30, 2009; 54(1): 1 - 15. [Abstract] [Full Text] [PDF]

				E. Raichlin, A. Prasad, W. K. Kremers, B. S. Edwards, C. S. Rihal, A. Lerman, and S. S. Kushwaha Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients Eur. Heart J., June 1, 2009; 30(11): 1356 - 1363. [Abstract] [Full Text] [PDF]

				M. Naya, T. Tsukamoto, K. Morita, C. Katoh, T. Furumoto, S. Fujii, N. Tamaki, and H. Tsutsui Olmesartan, But Not Amlodipine, Improves Endothelium-Dependent Coronary Dilation in Hypertensive Patients J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1144 - 1149. [Abstract] [Full Text] [PDF]

				A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both? Eur. Heart J., April 1, 2007; 28(7): 788 - 797. [Abstract] [Full Text] [PDF]

				P. T. Siegrist, O. Gaemperli, P. Koepfli, T. Schepis, M. Namdar, I. Valenta, F. Aiello, S. Fleischmann, H. Alkadhi, and P. A. Kaufmann Repeatability of Cold Pressor Test-Induced Flow Increase Assessed with H215O and PET J. Nucl. Med., September 1, 2006; 47(9): 1420 - 1426. [Abstract] [Full Text] [PDF]

				G. Niccoli, G. A. Lanza, S. Shaw, E. Romagnoli, D. Gioia, F. Burzotta, C. Trani, M. A. Mazzari, R. Mongiardo, M. De Vita, et al. Endothelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization Eur. Heart J., August 1, 2006; 27(15): 1793 - 1798. [Abstract] [Full Text] [PDF]

				T. H. Schindler, J. Cardenas, J. O. Prior, A. D. Facta, M. C. Kreissl, X.-L. Zhang, J. Sayre, M. Dahlbom, J. Licinio, and H. R. Schelbert Relationship Between Increasing Body Weight, Insulin Resistance, Inflammation, Adipocytokine Leptin, and Coronary Circulatory Function J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1188 - 1195. [Abstract] [Full Text] [PDF]

				F. Tomai, F. Ribichini, A. S. Ghini, V. Ferrero, G. Ando, C. Vassanelli, F. Romeo, F. Crea, and L. Chiariello Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease Eur. Heart J., October 2, 2005; 26(20): 2099 - 2105. [Abstract] [Full Text] [PDF]

				T. H. Schindler, E. U. Nitzsche, H. R. Schelbert, M. Olschewski, J. Sayre, M. Mix, I. Brink, X.-L. Zhang, M. Kreissl, N. Magosaki, et al. Positron Emission Tomography-Measured Abnormal Responses of Myocardial Blood Flow to Sympathetic Stimulation Are Associated With the Risk of Developing Cardiovascular Events J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1505 - 1512. [Abstract] [Full Text] [PDF]

				E. Nygard, K. F. Kofoed, J. Freiberg, S. Holm, J. Aldershvile, K. Eliasen, and H. Kelbaek Effects of High Thoracic Epidural Analgesia on Myocardial Blood Flow in Patients With Ischemic Heart Disease Circulation, May 3, 2005; 111(17): 2165 - 2170. [Abstract] [Full Text] [PDF]

				A. N. Swafford Jr., I. N. Bratz, J. D. Knudson, P. A. Rogers, J. M. Timmerman, J. D. Tune, and G. M. Dick C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1786 - H1795. [Abstract] [Full Text] [PDF]